Zurcher Kantonalbank Zurich Cantonalbank Cuts Stake in Colgate-Palmolive (NYSE:CL)

Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 2.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 516,804 shares of the company's stock after selling 10,813 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned about 0.06% of Colgate-Palmolive worth $46,983,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. D Orazio & Associates Inc. lifted its stake in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock worth $297,000 after purchasing an additional 108 shares in the last quarter. Commonwealth Financial Services LLC increased its position in shares of Colgate-Palmolive by 4.5% in the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock valued at $247,000 after purchasing an additional 118 shares during the last quarter. Lantz Financial LLC lifted its stake in Colgate-Palmolive by 0.6% during the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock worth $1,831,000 after purchasing an additional 122 shares during the last quarter. Horizon Kinetics Asset Management LLC boosted its stake in Colgate-Palmolive by 4.2% in the third quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company's stock valued at $322,000 after acquiring an additional 124 shares in the last quarter. Finally, Pine Haven Investment Counsel Inc boosted its position in shares of Colgate-Palmolive by 1.0% in the 4th quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company's stock valued at $1,182,000 after purchasing an additional 130 shares during the period. Institutional investors own 80.41% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Piper Sandler cut their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday, January 6th. Stifel Nicolaus decreased their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research report on Monday, February 3rd. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Finally, Raymond James restated an "outperform" rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $101.61.

Colgate-Palmolive Price Performance

Shares of NYSE CL traded down $2.00 on Wednesday, hitting $92.10. The company's stock had a trading volume of 2,680,032 shares, compared to its average volume of 4,157,013. The stock has a 50 day moving average of $89.03 and a 200-day moving average of $94.99. The company has a market capitalization of $74.74 billion, a price-to-earnings ratio of 26.16, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company posted $0.87 EPS. As a group, research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.